期刊文献+

肝切除加区域化疗治疗原发性肝癌140例分析 被引量:1

暂未订购
导出
摘要 目的 探讨原发性肝癌的外科治疗方法。方法 回顾性分析肝切除加全置入式药物灌注装置 (TI -DDS)置入治疗 140例原发性肝癌的效果。结果 切除率 79.5 % ;术后 3 0天内病死率 3 .6% ,并发症发生率 2 0 % ;1、2、3、5年生存率分别为 70 .4%、5 0 .6%、2 9.2 %、10 .1%。结论 常温下间歇肝门阻断、刮吸断肝等方法在肝癌外科技术中具有实用价值 ;
出处 《徐州医学院学报》 CAS 2003年第1期74-75,共2页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献9

  • 1Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma[J]. J Am Coll Surg, 2000,191(4) :381 - 388.
  • 2吴孟超,陈汉,沈锋.原发性肝癌的外科治疗——附5524例报告[J].中华外科杂志,2001,39(1):25-28. 被引量:263
  • 3陈孝平.大肝癌外科治疗的选择[J].肝胆胰脾外科杂志,1997,3(2):117-118. 被引量:10
  • 4Fan ST, Lo CM, Liu CT, et al. Hepatectomy for hepatocellular carcinoma, toward zero hospital death[J]. Ann Surg, 1999,229(3) :322 -330.
  • 5Adachi E, Maehara S, Tsujita E,et al. Clinicopathologic risk factors for reourrence after a curative hepatic resection for hepatocellular carcinoma[J]. Surgery, 2002,131(Suppl 1):148- 152.
  • 6Papadimitriou JD, Fotopoulos AC, Prahalias AA,et al. The impact of new technology on hepatic resection for malignancy [ J ]. Arch Surg,2001,136( 11 ): 1307 - 1313.
  • 7Kanematsu T, Furui J, Yanaga K, et al. A 16 - year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985 - 2000[J]. Surgery, 2002,131 (Suppl 1 ): 153 - 158.
  • 8Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma[J]. Ann Surg, 2000,232( 1 ): 10 - 24.
  • 9林芷英,任正刚,夏景林,陈漪,吴晓凤,马曾辰,叶青海,钦伦秀,孙惠川,汤钊猷.原发性肝癌根治切除后介入治疗对复发防治的疗效评价[J].中华肿瘤杂志,2000,22(4):315-317. 被引量:55

二级参考文献10

共引文献323

同被引文献7

  • 1吴孟超,陈汉,姚晓平,杨甲酶,杨广顺,沈锋.原发性肝癌的外科治疗[J].中华外科杂志,1996,34(12):707-710. 被引量:121
  • 2lshikawa M, Yogita S, Miyake H, et al, Clarification of risk factors for hepatectomy in patients with hepatocellularcar cinoma [J].Hepatogastroenterology. 2002, 49 ( 48 ) : 1625-1631.
  • 3Wei ACoTung-Ping Poon R,et al, Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma[J], Br J Sarg, 2003.90( 1 ) : 33-41.
  • 4Ercolani G,Grazi GL.Calliva R,et al. The lidocaine(MEGX) testas an idex of hepatic function: its clinical usefulness in liver surgery[J]. Surgery, 2000,127 (4) : 464-471.
  • 5Christians KK. Pitt HA, Rilling WS, et al. Hepatocellular carcinoma : multimodality management [J ]. Surgery, 2001.130(4) :554-559.
  • 6Torzilli G, Makuuchi M. Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients :is there a way? A prospective analysis of our approach[J]. Arch Surg,1999, 134(9) :984-992.
  • 7淮明生,戴朝六,朱兴,田大治,张旭.肝癌患者术前ICGR_(15)水平与术后并发症的相关分析[J].肝胆外科杂志,2002,10(1):31-33. 被引量:16

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部